These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 31387805)
1. IL-17F expression correlates with clinicopathologic factors and biological markers in non-small cell lung cancer. Li C; Ma X; Tan C; Fang H; Sun Y; Gai X Pathol Res Pract; 2019 Oct; 215(10):152562. PubMed ID: 31387805 [TBL] [Abstract][Full Text] [Related]
2. Clinicopathological significance of lymphatic vessel density marked by D2-40 and E-cadherin expression in non-small-cell lung cancer. Jin S; Zhu W; Shi Q; Zhang Z; Guo R Med Oncol; 2012 Dec; 29(5):3157-61. PubMed ID: 22528515 [TBL] [Abstract][Full Text] [Related]
3. PBK/TOPK expression in non-small-cell lung cancer: its correlation and prognostic significance with Ki67 and p53 expression. Lei B; Liu S; Qi W; Zhao Y; Li Y; Lin N; Xu X; Zhi C; Mei J; Yan Z; Wan L; Shen H Histopathology; 2013 Nov; 63(5):696-703. PubMed ID: 24025073 [TBL] [Abstract][Full Text] [Related]
4. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells. Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207 [TBL] [Abstract][Full Text] [Related]
5. Detection of Brk expression in non-small cell lung cancer: clinicopathological relevance. Fan C; Zhao Y; Liu D; Zhang X; Wang E Tumour Biol; 2011 Oct; 32(5):873-80. PubMed ID: 21603980 [TBL] [Abstract][Full Text] [Related]
6. Expression of miR-150 and miR-3940-5p is reduced in non-small cell lung carcinoma and correlates with clinicopathological features. Sun Y; Su B; Zhang P; Xie H; Zheng H; Xu Y; Du Q; Zeng H; Zhou X; Chen C; Gao W Oncol Rep; 2013 Feb; 29(2):704-12. PubMed ID: 23228962 [TBL] [Abstract][Full Text] [Related]
7. Krüppel-Like Factor 8 Overexpression Correlates with Poor Prognosis in Non-Small Cell Lung Cancer. Li J; Liu Y; Xue J; Xu M; Zhang J; Liu J; Wang W Pathol Oncol Res; 2019 Jan; 25(1):115-121. PubMed ID: 28986741 [TBL] [Abstract][Full Text] [Related]
8. Expression of hypoxia-inducible factor prolyl hydroxylase 3 HIFPH3 in human non-small cell lung cancer (NSCLC) and its correlation with prognosis. Chu X; Zhu CC; Liu H; Wang JC Asian Pac J Cancer Prev; 2014; 15(14):5819-23. PubMed ID: 25081707 [TBL] [Abstract][Full Text] [Related]
9. [Expression of alpha-tubulin and MDR1 and their correlation with the biological features of non-small cell lung carcinoma]. Chen QY; Jiang ZY; Wu LJ; Zhang BY; Lu GH; Zhou JY Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):278-82. PubMed ID: 20510079 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of CD88 predicts poor prognosis in non-small-cell lung cancer. Gu J; Ding JY; Lu CL; Lin ZW; Chu YW; Zhao GY; Guo J; Ge D Lung Cancer; 2013 Aug; 81(2):259-65. PubMed ID: 23706417 [TBL] [Abstract][Full Text] [Related]
11. Expression of connexin 43 and E-cadherin protein and mRNA in non-small cell lung cancers in Chinese patients. Zhao JQ; Sun FJ; Liu SS; Yang J; Wu YQ; Li GS; Chen QY; Wang JX Asian Pac J Cancer Prev; 2013; 14(2):639-43. PubMed ID: 23621211 [TBL] [Abstract][Full Text] [Related]
12. [Abnormal expression of Thy-1 as a novel tumor marker in lung cancer and its prognostic significance]. Chen JF; Zhang LJ; Zhao AL; Wang Y; Wu N; Xiong HC; Liang Z; Li JY; Huang XF; Yang Y Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1921-5. PubMed ID: 16255990 [TBL] [Abstract][Full Text] [Related]
13. [Expression of ezrin in human non-small cell lung cancer and its relationship with metastasis and prognosis]. Chen QY; Yan J; Hu HZ; Chen FY; Song J; Jiang ZY; Jiao DM; Wu YQ Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):436-40. PubMed ID: 22967445 [TBL] [Abstract][Full Text] [Related]
14. [Inverse correlation of S100A4 and E-cad protein expression and their clinical significance in non-small cell lung cancer]. Qi RX; Xu XY Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):681-4. PubMed ID: 18246798 [TBL] [Abstract][Full Text] [Related]
15. Expression of IL-17A, E, and F and their receptors in non-small-cell lung cancer. Huang Q; Ma XC; Yang X; Wang W; Li Y; Lv Z; Corrigan CJ; Chen Y; Ying S J Biol Regul Homeost Agents; 2018; 32(5):1105-1116. PubMed ID: 30334403 [TBL] [Abstract][Full Text] [Related]
16. Expressions of KAI1 and E-cadherin in nonsmall cell lung cancer and their correlation with vasculogenic mimicry. Ci H; Xu Z; Xu J; Wang Y; Wu S Medicine (Baltimore); 2018 Oct; 97(40):e12293. PubMed ID: 30290593 [TBL] [Abstract][Full Text] [Related]
17. An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker. Wei K; Ye Z; Li Z; Dang Y; Chen X; Huang N; Bao C; Gan T; Yang L; Chen G World J Surg Oncol; 2016 Feb; 14(1):34. PubMed ID: 26860827 [TBL] [Abstract][Full Text] [Related]
18. [Expressions of Nm23, E-cadherin, and beta-catenin in non-small cell lung cancer and their correlations with metastasis and prognosis]. Tang XJ; Zhou QH; Zhang SF; Liu LX Ai Zheng; 2005 May; 24(5):616-21. PubMed ID: 15890109 [TBL] [Abstract][Full Text] [Related]
19. Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer. Huang Q; Fan J; Qian X; Lv Z; Zhang X; Han J; Wu F; Chen C; Du J; Guo M; Hu G; Jin Y J Cancer Res Clin Oncol; 2016 Jan; 142(1):263-72. PubMed ID: 26319393 [TBL] [Abstract][Full Text] [Related]
20. Epithelial-Mesenchymal Transition in Non Small-cell Lung Cancer. Tsoukalas N; Aravantinou-Fatorou E; Tolia M; Giaginis C; Galanopoulos M; Kiakou M; Kostakis ID; Dana E; Vamvakaris I; Korogiannos A; Tsiambas E; Salemis N; Kyrgias G; Karameris A; Theocharis S Anticancer Res; 2017 Apr; 37(4):1773-1778. PubMed ID: 28373440 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]